Sleep IntervEntion as Symptom Treatment for ADHD

NCT ID: NCT04723719

Last Updated: 2024-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-28

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Up to 72% of adolescents with ADHD portray sleep problems. The most common sleep difficulties in adolescents with ADHD are initial insomnia, nocturnal awakenings, non-restorative or restless sleep. These difficulties seem to be causally related to increased ADHD symptom impairment, oppositional and depressive symptomatology, and functional impairments in daily life, resulting in a vicious circle of sleep problems and impairment. Thus, reducing sleep problems is an important intervention target. However, to date there is no evidence-based cognitive behavioral sleep treatment available. Sleep-focused treatments need adaptation towards this developmental phase/disorder for effectiveness, as ADHD and sleep problems are bi-directional. Therefore, a blended treatment targeting the core deficits integrating motivational interviewing, planning skills and sleep interventions is needed. Thus, the aim of this project is testing the short and 3 months follow-up effectiveness of the blended CBT sleep intervention in adolescents with ADHD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD Sleep Adolescents CBT

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial with training group and control group.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
Stratified permuted block randomization, controlling for ADHD medication use (yes/no), is done by a masked/independent researcher.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SIESTA training + treatment as usual for ADHD

We developed a cognitive behavioral therapy for sleep problems in adolescents with ADHD. This includes seven individual sessions with the adolescent and two individual sessions with the parent(s)/guardian(s). Participants receive this CBT training called SIESTA next to their treatment as usual for ADHD symptomatology (mostly ADHD-medication).

Group Type EXPERIMENTAL

SIESTA

Intervention Type BEHAVIORAL

SIESTA is a CBT sleep training for adolescents with ADHD with a focus on sleep hygiene, motivational interviewing and planning and organization.

Treatment as usual for ADHD

Intervention Type OTHER

Participants continue their treatment as usual for ADHD.

Treatment as usual for ADHD only

Participants continue their treatment as usual for ADHD (mostly ADHD-medication).

Group Type ACTIVE_COMPARATOR

Treatment as usual for ADHD

Intervention Type OTHER

Participants continue their treatment as usual for ADHD.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SIESTA

SIESTA is a CBT sleep training for adolescents with ADHD with a focus on sleep hygiene, motivational interviewing and planning and organization.

Intervention Type BEHAVIORAL

Treatment as usual for ADHD

Participants continue their treatment as usual for ADHD.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sleep IntervEntion as Symptom Treatment for ADHD TAU

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Attending secondary education and between 13-17 years old
2. prior diagnosis of ADHD (any presentation) and confirmation of DSM-5 criteria of ADHD in current study
3. Displaying sleep problems for at least 3 nights per week for at least 3 months

1. sleep onset latency of at least 20-30 minutes
2. and/or wake after sleep onset greater than 30 min
3. and/or an average sleep time of less than 7 hours
4. and at least one poor sleep hygiene practice
5. and experienced distress as indicated by parent/guardian and/or adolescent.
4. estimated IQ≥80
5. stable ADHD medication use at least 4 weeks before start of treatment and no dose or medication type changes planned during active treatment

Exclusion Criteria

1. the following comorbidities: sleep-breathing disorder, restless leg syndrome, narcolepsy, conduct disorder, depressive disorder with suicide risk or active suicidality, autism spectrum disorder, or substance use disorder, with an exception for nicotine
2. acute crisis situation at home
3. physical problems that interfere with sleep (e.g. pain) or medical disorders and related medication that could affect sleep
4. participation in a behaviorally based sleep intervention in the 6 months prior to our study
5. currently taking pharmacological medication for sleep (including melatonin), anxiety or depression. Participation will be allowed after a two-week wash-out period of the medication
Minimum Eligible Age

13 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Research Foundation Flanders

OTHER

Sponsor Role collaborator

KU Leuven

OTHER

Sponsor Role collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Saskia Van der Oord

Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saskia Van der Oord, PhD

Role: PRINCIPAL_INVESTIGATOR

KU Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UPC Leuven

Leuven, Vlaams Brabant, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

References

Explore related publications, articles, or registry entries linked to this study.

Keuppens L, Marten F, Baeyens D, Boyer B, Danckaerts M, van der Oord S. Sleep IntervEntion as Symptom Treatment for ADHD (SIESTA)-Blended CBT sleep intervention to improve sleep, ADHD symptoms and related problems in adolescents with ADHD: Protocol for a randomised controlled trial. BMJ Open. 2023 Apr 13;13(4):e065355. doi: 10.1136/bmjopen-2022-065355.

Reference Type DERIVED
PMID: 37055205 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UZ Leuven

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CBT-I in Adolescents With ADHD
NCT07209969 ACTIVE_NOT_RECRUITING NA
Cognitive Training Trial
NCT01133418 COMPLETED NA
rTMS in Children and Adolescents With ADHD:
NCT06389864 NOT_YET_RECRUITING NA